Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure
Aim. To assess the effect of renal dysfunction on the galectin-3 level in patients with chronic heart failure (HF) with preserved, intermediate and reduced left ventricular ejection fraction (EF).Material and methods. Along with a clinical examination, 69 patients with HF (NYHA class II-IV) underwen...
Saved in:
Main Authors: | V. I. Podzolkov, N. A. Dragomiretskaya, A. V. Kazadaeva, Yu. G. Belyaev, A. V. Tolmacheva |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2022-05-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/2709 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Cystatin C and Galectin-3 in Cardiorenal Syndrome
by: Nazar Ahemd Naji, et al.
Published: (2023-02-01) -
Cardiorenal syndrome in patients with chronic heart failure
by: L. A. Kovalevskaya, et al.
Published: (2015-08-01) -
Causes of development and progression of cardiorenal syndrome in heart failure patients. Prevention methods
by: V. V. Davydov, et al.
Published: (2021-02-01) -
Relationships between the activity of neurohormonal systems and intracardiac hemodynamics in patients with heart failure: focus on galectin-3
by: V. I. Podzolkov, et al.
Published: (2022-05-01) -
CARDIORENAL SYNDROME IN CHRONIC HEART FAILURE: PATHOGENESIS, DIAGNOSTICS, PROGNOSIS AND OPPORTUNITIES FOR TREATMENT
by: E. A. Medvedeva, et al.
Published: (2017-02-01)